Bensman, Timothy J <br/><br/>
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  10 2017 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Journal Article 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.00988-17  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anti-Bacterial Agents--pharmacokinetics<br/>Azabicyclo Compounds--pharmacokinetics<br/>Ceftazidime--pharmacokinetics<br/>Cystic Fibrosis--pathology<br/>Drug Combinations<br/>Female<br/>Humans<br/>Male<br/>Microbial Sensitivity Tests<br/>Middle Aged<br/>Monte Carlo Method<br/>Prospective Studies<br/>Pseudomonas Infections--drug therapy<br/>Pseudomonas aeruginosa--drug effects<br/>Respiratory Tract Infections--drug therapy<br/>Young Adult<br/>beta-Lactamase Inhibitors--pharmacokinetics